1947 related articles for article (PubMed ID: 30600478)
1. Goals and targets for personalized therapy for HCC.
Couri T; Pillai A
Hepatol Int; 2019 Mar; 13(2):125-137. PubMed ID: 30600478
[TBL] [Abstract][Full Text] [Related]
2. Management of hepatocellular in the United States.
Mokdad AA; Hester CA; Singal AG; Yopp AC
Chin Clin Oncol; 2017 Apr; 6(2):21. PubMed ID: 28482674
[TBL] [Abstract][Full Text] [Related]
3. Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system.
Han K; Kim JH
World J Gastroenterol; 2015 Sep; 21(36):10327-35. PubMed ID: 26420959
[TBL] [Abstract][Full Text] [Related]
4. Treatment algorithm for intermediate and advanced stage hepatocellular carcinoma: Korea.
Choi JY
Oncology; 2011; 81 Suppl 1():141-7. PubMed ID: 22212948
[TBL] [Abstract][Full Text] [Related]
5. Image-guided percutaneous locoregional therapies for hepatocellular carcinoma.
Chevallier O; Zhao K; Marinelli B; Yarmohammadi H
Chin Clin Oncol; 2023 Apr; 12(2):17. PubMed ID: 37081710
[TBL] [Abstract][Full Text] [Related]
6. [Hepatocellular Carcinoma: therapeutic options 2015].
Schultheiß M; Bettinger D; Neeff HP; Brunner TB; Thimme R
Dtsch Med Wochenschr; 2015 Jul; 140(14):1063-8. PubMed ID: 26182255
[TBL] [Abstract][Full Text] [Related]
7. Management of Hepatocellular Carcinoma: Current Status and Future Directions.
Au JS; Frenette CT
Gut Liver; 2015 Jul; 9(4):437-48. PubMed ID: 26087860
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the treatment response of HCC.
Kim KW; Lee JM; Choi BI
Abdom Imaging; 2011 Jun; 36(3):300-14. PubMed ID: 21279353
[TBL] [Abstract][Full Text] [Related]
9. Intermediate hepatocellular carcinoma: current treatments and future perspectives.
Dufour JF; Bargellini I; De Maria N; De Simone P; Goulis I; Marinho RT
Ann Oncol; 2013 Apr; 24 Suppl 2():ii24-9. PubMed ID: 23715940
[TBL] [Abstract][Full Text] [Related]
10. Overall survival in response to sorafenib with transarterial chemoembolization for BCLC stage B hepatocellular carcinoma: propensity score analysis
.
Huang Y; Chen B; Liu N; Li N; Dao H; Chen W; Yang J
Int J Clin Pharmacol Ther; 2017 Jun; 55(6):498-508. PubMed ID: 28157070
[TBL] [Abstract][Full Text] [Related]
11. Advanced HCC: emerging molecular therapies.
Finn RS
Minerva Gastroenterol Dietol; 2012 Mar; 58(1):25-34. PubMed ID: 22419002
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Factors for Survival After Transarterial Chemoembolization Combined with Sorafenib in the Treatment of BCLC Stage B and C Hepatocellular Carcinomas.
Ni JY; Kong J; Sun HL; Chen YT; Luo JH; Wang WD; Chen D; Jiang XY; Xu LF
Acad Radiol; 2018 Apr; 25(4):423-429. PubMed ID: 29198946
[TBL] [Abstract][Full Text] [Related]
13. Asian consensus workshop report: expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in Asia.
Han KH; Kudo M; Ye SL; Choi JY; Poon RT; Seong J; Park JW; Ichida T; Chung JW; Chow P; Cheng AL
Oncology; 2011; 81 Suppl 1():158-64. PubMed ID: 22212951
[TBL] [Abstract][Full Text] [Related]
14. Management of HCC.
de Lope CR; Tremosini S; Forner A; Reig M; Bruix J
J Hepatol; 2012; 56 Suppl 1():S75-87. PubMed ID: 22300468
[TBL] [Abstract][Full Text] [Related]
15. Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma.
Pecorelli A; Lenzi B; Gramenzi A; Garuti F; Farinati F; Giannini EG; Ciccarese F; Piscaglia F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Sacco R; Cabibbo G; Felder M; Morisco F; Gasbarrini A; Baroni GS; Foschi FG; Biasini E; Masotto A; Virdone R; Bernardi M; Trevisani F;
Liver Int; 2017 Mar; 37(3):423-433. PubMed ID: 27566596
[TBL] [Abstract][Full Text] [Related]
16. Treatment allocation in hepatocellular carcinoma: Assessment of the BCLC algorithm.
Richani M; Kolly P; Knoepfli M; Herrmann E; Zweifel M; von Tengg-Kobligk H; Candinas D; Dufour JF
Ann Hepatol; 2016; 15(1):82-90. PubMed ID: 26626644
[TBL] [Abstract][Full Text] [Related]
17. Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective.
Su TH; Wu CH; Liu TH; Ho CM; Liu CJ
Clin Mol Hepatol; 2023 Apr; 29(2):230-241. PubMed ID: 36710607
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma: Dutch guideline for surveillance, diagnosis and therapy.
Eskens FA; van Erpecum KJ; de Jong KP; van Delden OM; Klumpen HJ; Verhoef C; Jansen PL; van den Bosch MA; Méndez Romero A; Verheij J; Bloemena E; de Man RA
Neth J Med; 2014 Jul; 72(6):299-304. PubMed ID: 25319854
[TBL] [Abstract][Full Text] [Related]
19. Interventional treatment for unresectable hepatocellular carcinoma.
Murata S; Mine T; Sugihara F; Yasui D; Yamaguchi H; Ueda T; Onozawa S; Kumita S
World J Gastroenterol; 2014 Oct; 20(37):13453-65. PubMed ID: 25309076
[TBL] [Abstract][Full Text] [Related]
20. [Multimodal treatment of hepatocellular carcinoma].
Kirstein MM; Wirth TC
Internist (Berl); 2020 Feb; 61(2):164-169. PubMed ID: 31919533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
